Masaki T

No ORCID on file · 5 papers in corpus · active 1990-2022

Study types

  • article 2
  • other 1

Condition tags

  • endometriosis 3
2022
International journal of molecular sciences ·doi:10.3390/ijms23031667

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and is one of the leading causes of cancer-related deaths worldwide. Regorafenib, a multi-kinase inhibitor, is used as a second-line treatment for advanced HC…

2017
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract ·doi:10.1007/s11605-017-3503-1

BackgroundPostoperative adhesions are the major cause of postoperative complications including intestinal obstruction, infertility, and chronic pelvic pain. In order to reduce postoperative adhesions, Terumo Corporation (Tokyo, Japan) has d…

other 2014
European journal of pharmacology ·doi:10.1016/j.ejphar.2013.12.001

TAK-385 (relugolix) is a novel, non-peptide, orally active gonadotropin-releasing hormone (GnRH) antagonist, which builds on previous work with non-peptide GnRH antagonist TAK-013. TAK-385 possesses higher affinity and more potent antagonis…

article 1991
Endocrinologia japonica ·doi:10.1507/endocrj1954.38.39

A new, simple experimental endometriosis model was established by auto-transplanting endometrial tissue fragments beneath kidney capsules in female rats. The transplanted endometrial tissue grew well, forming a fluid-filled cyst, which reac…

article 1990
Endocrinologia japonica ·doi:10.1507/endocrj1954.37.719

The therapeutic effect of sustained-release microspheres of a potent LHRH agonist (leuprorelin acetate) on experimental endometriosis in female rats was examined histologically. Endometriosis was produced in rats by autotransplantation of e…